Department of Biology, College of Natural Sciences, Kyungpook National University, Daegu, South Korea.
Gene. 2013 Apr 1;517(2):164-8. doi: 10.1016/j.gene.2013.01.010. Epub 2013 Jan 17.
CHARGE syndrome is an autosomal dominant congenital disorder known to be caused by the haploinsufficiency of the CHD7 gene. Heterozygous mutations in the CHD7 gene have been identified in approximately 60-70% of patients clinically diagnosed with CHARGE syndrome. Although there have been many reports on the mutational spectrum of the CHD7 gene in patients with CHARGE syndrome worldwide, little is known about this syndrome in the Korean population. In this study, three Korean patients with CHARGE syndrome including one patient with Patau syndrome were evaluated for genetic analysis of the CHD7 gene using direct sequencing of all 38 exons and the flanking intronic regions. One nonsense and two novel missense mutations were identified in the CHD7 gene. Clinical symptoms caused by the missense mutations were much milder compared to the nonsense mutation, confirming the previously determined genotype-phenotype correlation in CHARGE syndrome. Our study demonstrates the importance of mutational screening of CHD7 in patients who have been diagnosed with other syndromes but display clinical features of CHARGE syndrome.
CHARGE 综合征是一种常染色体显性遗传的先天性疾病,已知由 CHD7 基因突变导致的单倍体功能不全引起。约 60-70%临床诊断为 CHARGE 综合征的患者中存在 CHD7 基因的杂合突变。尽管全世界已经有许多关于 CHARGE 综合征患者 CHD7 基因突变谱的报道,但对韩国人群中的这种综合征知之甚少。在这项研究中,通过对所有 38 个外显子和侧翼内含子区域进行直接测序,对包括一名 Patau 综合征患者在内的 3 名韩国 CHARGE 综合征患者进行了 CHD7 基因突变的遗传分析。在 CHD7 基因中发现了一个无义突变和两个新的错义突变。与无义突变相比,错义突变引起的临床症状要轻得多,这证实了 CHARGE 综合征中先前确定的基因型-表型相关性。我们的研究表明,对已被诊断为其他综合征但具有 CHARGE 综合征临床特征的患者进行 CHD7 基因突变筛查非常重要。